Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Cerence Q2 2024 Adj EPS $(0.09) Beats $(0.22) Estimate, Sales $67.800M Beat $62.149M Estimate

Author: Benzinga Newsdesk | May 09, 2024 07:06am
Cerence (NASDAQ:CRNC) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.22) by 59.09 percent. The company reported quarterly sales of $67.800 million which beat the analyst consensus estimate of $62.149 million by 9.09 percent. This is a 0.87 percent decrease over sales of $68.393 million the same period last year.

Posted In: CRNC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist